Litigation Update: JPML to Decide on Elmiron’s Litigation Venue

by | Dec 9, 2020

At the last JPML hearing held on Thursday, December 4th, the panel heard from counsel for Johnson & Johnson and lawyers for plaintiffs.  Both sides presented arguments for creating an MDL for all Elmiron cases in New Jersey federal court.  Those proposing NJ as the appropriate venue, stated that U.S. District Judge Brian Martinotti in New Jersey has already been handling Elmiron cases and has implemented processes to handle the suits that are commonly accepted in mass tort litigation.  Additionally, defendant and J&J’s subsidiary, Janssen Pharmaceuticals Inc., who has allegedly failed to warn consumers of the serious eye damage that Elmiron could cause, is located in NJ along with most of the witnesses and documentation.

On the other side of this argument, some plaintiff lawyers are requesting the litigation to be consolidated in Pennsylvania claiming that the cases in that jurisdiction are further along in the legal process, which NJ proponents argued is not an accurate assessment of the relative status of the litigation in each venue.

Click on this link for information on Verus’ Mass Tort Services. To contact us, fill out this form or email us at and we will reply immediately.

About the Author


Share This